Steve Charles, MD
Retina Specialist · Germantown, TNNPI 1861495780
Payments from drug & device makers
Across 680 payments — averaging $15,014 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4.4M
- Novartis$2.2M
- Genentech, Inc.$1.6M
- Alcon Research LLC$1.2M
- Bayer$250K
- Regeneron$209K
- plus $344K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 132 | $4,407,278 |
| Novartis | 46 | $2,158,935 |
| Genentech, Inc. | 103 | $1,613,092 |
| Alcon Research LLC | 183 | $1,227,989 |
| Bayer | 72 | $249,523 |
| Regeneron | 72 | $208,513 |
| Alcon Pharmaceuticals Ltd | 2 | $164,601 |
| Eyepoint US, Inc. | 5 | $132,247 |
| Optovue, Inc. | 1 | $35,000 |
| Travere Therapeutics, Inc. | 5 | $4,680 |
| Visionix USA, Inc | 1 | $3,780 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $1,581 |
| Alcon Grieshaber AG | 3 | $413 |
| Regeneron Healthcare Solutions, Inc. | 8 | $313 |
| Apellis Pharmaceuticals, Inc. | 10 | $304 |
| Genentech USA, Inc. | 7 | $246 |
| Mallinckrodt Hospital Products Inc. | 8 | $160 |
| AbbVie(2 entities) | 5 | $138 |
| Ocular Therapeutix, Inc. | 5 | $118 |
| F. Hoffmann-la Roche AG | 1 | $71 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Boston Scientific | 2 | $44 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Vyera Pharmaceuticals, LLC | 1 | $21 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $15 |
How this compares
$10,209,215 in reported general payments places this provider in the 95th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Germantown
- Stephen HuddlestonGermantown$10.9M
- Salar RafieetaryGermantown$37K
- Scott SullivanGermantown$5K
- David FingerhutGermantown$4K
- Kyle VinsonGermantown$2K
- Wesley GilletteGermantown$1K
- Carl AwhNashville$9.6M
- Eric SchneiderNashville$4M
- Brandon BusbeeNashville$1.7M
- John ElfervigMemphis$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.